MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Does Medtech Have an Appetite for M&A?—Boston Scientific

Does Medtech Have an Appetite for M&A?—Boston Scientific
Boston Scientific's Commentary on M&A"Near term, our capital allocation priorities are to prepay debt, manage our contingencies and pursue tuck-in M&A."

Boston Scientific's Commentary on M&A

"Near term, our capital allocation priorities are to prepay debt, manage our contingencies, and pursue tuck-in M&A."

Daniel Brennan, Boston Scientific CFO, according to a Seeking Alpha transcript of the company's first quarter earnings call

             

Get inspired to innovate in medtech at the MD&M East Conference, June 14-16, in New York City. 

[Image courtesy of STUART MILES/FREEDIGITALPHOTOS.NET]  

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish